ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75
  • Home
  • Archive
  • Contact
✕

News from the ECOG-ACRIN Cancer Research Group
September 19, 2025
Dr. O'Dwyer and Dr. Schnall
September 19, 2025
Categories
  • From the Co-Chairs

From the Co-Chairs, September 2025

An update on the cancer research environment, a recap of the September NCAB meeting, and a preview of the fall group meeting
Do you like it?
0 Read more
September 5, 2025
September 5, 2025
Categories
  • Active Clinical Trials

Now Enrolling: EA2234/STOPGAP II Study for Patients With Stomach Cancer Spread to the Abdominal Cavity

This clinical trial is testing a new treatment approach for patients with gastric carcinomatosis
Do you like it?
0 Read more
September 19, 2025
September 19, 2025
Categories
  • Active Clinical Trials

Amended Trial: Bradley Zebrack Gives an Update on the EAQ211 Trial for Adolescent and Young Adult Cancer Survivors

Changes broaden eligibility for this study of how adverse life experiences alter genes, immune cells, and subsequent health outcomes
Do you like it?
0 Read more
September 19, 2025
September 19, 2025
Categories
  • Institution Spotlights

Institution Spotlight: Delaware/ChristianaCare NCORP

A member of ECOG-ACRIN since 1998
Do you like it?
0 Read more
September 19, 2025
News in Brief
September 19, 2025
Categories
  • News in Brief

News in Brief, September 2025

Timely information about research presented at medical meetings, recognition of research leaders, and more
Do you like it?
0 Read more

A blog to share information with our members, staff, and the cancer research community

✕

Categories

  • From the Co-Chairs
  • Active Clinical Trials
  • Institution Spotlights
  • Special Topics
  • People
  • News in Brief
  • Trial Results
  • Active ECOG-ACRIN Trials
  • ECOG-ACRIN.org

Tags

Acute lymphoblastic leukemia (ALL) Advanced practice providers Advocacy ASCO Breast cancer Cancer care delivery research Cancer control Cancer screening Cancer surveillance Chemotherapy Clinical trials Colorectal cancer Comis Symposium Communication COVID-19 GI cancer Group Meeting Head and neck cancer Head and neck squamous cell carcinoma Health equity Immunotherapy In memory Kidney cancer Leadership Leukemia Lung cancer Lymphoma Melanoma Mentorship Myeloma NCI NCI-MATCH NCORP Non-small cell lung cancer Pancreatic cancer Patient-reported outcomes Precision medicine Prevention Prostate cancer Real-world data Research results Sarcoma Survivorship Targeted therapy TMIST
STAY UP TO DATE

Opt in to ensure we deliver this monthly blog directly to your inbox. We will never share your email.

Select list(s) to subscribe to


Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2025 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc